ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
FTSE 100
8,128.76
0.54%
Dow Jones
43,544.49
0.31%
Gold vs US Dollar
2,668.06
0.59%
Brent Oil
73.665
1.13%
Bitcoin
96,295.60
2.05%
Pepperstone
Advertisement
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE
  6. Fusion Antibodies Plc (FAB)

  7. Fusion Antibodies Plc (FAB) News

Fusion Antibodies (FAB)

Fusion Antibodies Plc
Date:
Sort by:
 Showing the most relevant articles for your search:LSE:FAB
DateTimeSourceHeadlineSymbolCompany
19/11/202413:10Alliance NewsAlliance NewsFusion Antibodies interim loss narrows as revenue more than doublesLSE:FABFusion Antibodies Plc
19/11/202407:00RNS Regulatory NewsFusion Antibodies PLC Half-year ReportLSE:FABFusion Antibodies Plc
16/10/202412:23RNS Regulatory NewsFusion Antibodies PLC Director/PDMR ShareholdingLSE:FABFusion Antibodies Plc
16/10/202406:00RNS Regulatory NewsFusion Antibodies PLC Issue of shares to non-executive directorsLSE:FABFusion Antibodies Plc
08/10/202412:58Alliance NewsAlliance NewsIN BRIEF: Fusion Antibodies expects interim revenue to doubleLSE:FABFusion Antibodies Plc
08/10/202411:32RNS Regulatory NewsFusion Antibodies PLC Result of AGMLSE:FABFusion Antibodies Plc
08/10/202406:00RNS Regulatory NewsFusion Antibodies PLC AGM statement and trading updateLSE:FABFusion Antibodies Plc
02/10/202406:00RNS Regulatory NewsFusion Antibodies PLC Block admission six monthly returnLSE:FABFusion Antibodies Plc
12/09/202408:54RNS Regulatory NewsFusion Antibodies PLC Notice of AGMLSE:FABFusion Antibodies Plc
09/09/202411:35RNS Regulatory NewsFusion Antibodies PLC Director/PDMR ShareholdingLSE:FABFusion Antibodies Plc
09/09/202406:00RNS Non-RegulatoryFusion Antibodies PLC Investor presentationLSE:FABFusion Antibodies Plc
05/09/202411:15RNS Regulatory NewsFusion Antibodies PLC Director/PDMR ShareholdingLSE:FABFusion Antibodies Plc
05/09/202406:00RNS Regulatory NewsFusion Antibodies PLC Final ResultsLSE:FABFusion Antibodies Plc
28/08/202412:52Alliance NewsAlliance NewsFusion Antibodies expands agreement with National Cancer InstituteLSE:FABFusion Antibodies Plc
28/08/202406:00RNS Non-RegulatoryFusion Antibodies PLC Expansion to OptiMAL collaboration agreementLSE:FABFusion Antibodies Plc
22/07/202411:54RNS Regulatory NewsFusion Antibodies PLC Director/PDMR ShareholdingLSE:FABFusion Antibodies Plc
18/07/202406:00RNS Non-RegulatoryFusion Antibodies PLC Launch of New Interactive Investor HubLSE:FABFusion Antibodies Plc
04/07/202412:33Alliance NewsAlliance NewsTRADING UPDATES: itim signs contract; Tekmar renews banking facilitiesLSE:FABFusion Antibodies Plc
04/07/202406:00RNS Regulatory NewsFusion Antibodies PLC Trading updateLSE:FABFusion Antibodies Plc
23/05/202420:08Alliance NewsAlliance NewsTRADING UPDATES: Celadon ships to US; Oxford BioDynamics-Goodbody pactLSE:FABFusion Antibodies Plc
23/05/202406:00RNS Regulatory NewsFusion Antibodies PLC New contract with existing clientLSE:FABFusion Antibodies Plc
02/05/202406:00RNS Non-RegulatoryFusion Antibodies PLC Investor presentationLSE:FABFusion Antibodies Plc
30/04/202418:54Alliance NewsAlliance NewsEARNINGS AND TRADING: Software Circle & Beximco report higher revenueLSE:FABFusion Antibodies Plc
30/04/202406:00RNS Regulatory NewsFusion Antibodies PLC Year-end trading statementLSE:FABFusion Antibodies Plc
16/04/202406:00RNS Regulatory NewsFusion Antibodies PLC Change of auditorLSE:FABFusion Antibodies Plc
15/04/202412:29Alliance NewsAlliance NewsFusion Antibodies inks commercial contract for OptiPhage libraryLSE:FABFusion Antibodies Plc
15/04/202406:00RNS Regulatory NewsFusion Antibodies PLC Contract to develop a bespoke OptiPhage libraryLSE:FABFusion Antibodies Plc
02/04/202413:34RNS Regulatory NewsFusion Antibodies PLC Block admission six monthly returnLSE:FABFusion Antibodies Plc
28/03/202417:00RNS Regulatory NewsFusion Antibodies PLC Total Voting RightsLSE:FABFusion Antibodies Plc
11/03/202415:04RNS Regulatory NewsFusion Antibodies PLC Holding(s) in CompanyLSE:FABFusion Antibodies Plc
 Showing the most relevant articles for your search:LSE:FAB

Your Recent History

LSE
DEC
Diversified Energy
LSE
VAST
Vast Resources
LSE
POS
Plexus
LSE
SYME
Supply@me Capital
LSE
MIN
Minoan
LSE
LIO
Liontrust Asset Management
LSE
STX
Shield Therapeutics
LSE
AAZ
Anglo Asian Mining
LSE
ITM
Itm Power
LSE
GGP
Greatland Gold
LSE
NEXN
Nexxen
LSE
TERN
Tern
LSE
LLOY
Lloyds Banking
LSE
BOO
Boohoo
LSE
THG
Thg
LSE
TW.
Taylor Wimpey
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved

    BLACK FRIDAY

    ADVFN

    Celebrating 25 years Est 1999-2024

    Save up to 60%* for Level 2 Lite

    1 year 40%, 2 years 50% and *3 years 60%
    EU Flag

    *Across 3 years £2132.64 only £853.06